Reply to Scheper and de Boer's comment on “Duration of rifampin therapy is a key determinant of improved outcomes in early-onset acute prosthetic joint infection due to Staphylococcus treated with a debridement, antibiotics and implant retention (DAIR): a retrospective multicenter study in France” by Becker et al. (2020)

Detalles Bibliográficos
Autores principales: Becker, Agathe, Kreitmann, Louis, Ferry, Tristan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Copernicus GmbH 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7517665/
https://www.ncbi.nlm.nih.gov/pubmed/32983844
http://dx.doi.org/10.5194/jbji-6-19-2020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7517665/
https://www.ncbi.nlm.nih.gov/pubmed/32983844
http://dx.doi.org/10.5194/jbji-6-19-2020

Ejemplares similares